The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.
Open accessAbstract
Individuals with one aerodigestive tract malignancy have a high incidence of second primary aerodigestive tumors. The mechanism for this field effect has not been determined. We studied an individual with widespread dysplastic changes in the respiratory epithelium but no overt carcinoma. The entire tracheobronchial tree obtained at autopsy was embedded in paraffin, and bronchial epithelial cells were isolated by microdissection. DNA extracted from the microdissected cells was analyzed for point mutations in the p53 tumor suppressor gene. A single, identical point mutation consisting of a G:C to T:A transversion in codon 245 was identified in bronchial epithelium from 7 of 10 sites in both lungs. Epithelium at sites containing the p53 mutation was morphologically abnormal, exhibiting squamous metaplasia and mild to moderate atypia. No invasive tumor was found in the tracheobronchial tree or any other location. Cells from peripheral blood, kidney, liver, and lymph node exhibited no abnormality in the p53 gene. The widespread presence of a single somatic p53 point mutation in the bronchi of a smoker suggests that a single progenitor bronchial epithelial clone may expand to populate broad areas of the bronchial mucosa-a novel mechanism for field carcinogenesis in the respiratory epithelium that may be of importance in assessing individuals for risk of a second primary tumor as well as in devising effective strategies for chemoprevention of lung cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Slaughter, D. P., Southwick, H. W., & Smejkal, W. (1953) · Cancer · doi:10.1002/1097-0142(195309)6:5<963::aid-cncr2820060515>3.0.co;2-q · Cited by 3,545
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
The multistep nature of cancer
Vogelstein, B., & Kinzler, K. W. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90209-z · Cited by 1,853
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Incidence of local recurrence and second primary tumors in resected stage I lung cancer
Martini, N., Bains, M. S., Burt, M. E., Zakowski, M. F., McCormack, P., Rusch, V. W., & Ginsberg, R. J. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70427-2 · Cited by 973
Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
Hartwell, L. (1992) · Cell · doi:10.1016/0092-8674(92)90586-2 · Cited by 770
Antioncogenes and human cancer.
Knudson, A. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10914 · Cited by 762
Clonal Origin of Bladder Cancer
Sidransky, D., Frost, P., Von Eschenbach, A., Oyasu, R., Preisinger, A. C., & Vogelstein, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203123261104 · Cited by 532
Clonal Genetic Alterations in the Lungs of Current and Former Smokers
Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Broxson, A., Khuri, F. R., Hong, W. K., Lee, J. J., Yu, R., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.12.857 · Cited by 453
Development of carcinoma of the lung as reflected in exfoliated cells
Saccomanno, G., Archer, V. E., Auerbach, O., Saunders, R. P., & Brennan, L. M. (1974) · Cancer · doi:10.1002/1097-0142(197401)33:1<256::aid-cncr2820330139>3.0.co;2-g · Cited by 414
Genetic alterations in the adenoma–carcinoma sequence
Cho, K. R., & Vogelstein, B. (1992) · Cancer · doi:10.1002/1097-0142(19920915)70:4+<1727::aid-cncr2820701613>3.0.co;2-p · Cited by 381
Hung, J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520310056030 · Cited by 339
NCI-navy medical oncology branch cell line data base
Phelps, R. M., Johnson, B. E., Ihde, D. C., Gazdar, A. F., Carbone, D. P., McClintock, P. R., Linnoila, R. I., Matthews, M. J., Bunn, P. A., Carney, D., et al. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630505 · Cited by 303
Self-citationChemical Carcinogenesis: From Animal Models To Molecular Models In One Decade
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60434-0 · Cited by 267
Strauss, B. S. (1991) · BioEssays · doi:10.1002/bies.950130206 · Cited by 263
Sundaresan, V., Ganly, P. S., Hasleton, P. S., Rudd, R., Sinha, G., Bleehen, N. M., & Rabbitts, P. H. (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90371-4 · Cited by 257
Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
Sozzi, G., Miozzo, M. R., Donghi, R., Pilotti, S., Cariani, C. T., Pastorino, U., Porta, G., & Pierotti, M. A. (1992) · PubMed · Cited by 250
Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.
Milner, J., Medcalf, E. A., & Cook, A. C. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.12 · Cited by 243
p53 Protein accumulates frequently in early bronchial neoplasia
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)90320-4 · Cited by 212
Antakli, T., Schaefer, R. F., Rutherford, J. E., & Read, R. C. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00067-u · Cited by 199
Diagnosis and management of synchronous lung cancers
Ferguson, M. K., DeMeester, T. R., DesLauriers, J., Little, A. G., Piraux, M., & Golomb, H. (1985) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)38787-2 · Cited by 165
p53 domains: structure, oligomerization, and transformation.
Wang, P., Reed, M., Wang, Y., Mayr, G., Stenger, J. E., Anderson, M. E., Schwedes, J. F., & Tegtmeyer, P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5182 · Cited by 161
Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions
Sozzi, G., Miozzo, M. R., Pastorino, U., Pilotti, S., Donghi, R., Giarola, M., Gregorio, L. D., Manenti, G., Radice, P., & Minoletti, F. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)90170-1 · Cited by 161
Multiple primary lung cancers. Results of surgical treatment.
Deschamps, C. C., Pairolero, P. C., Trastek, V. F., & Payne, W. S. (1990) · PubMed · Cited by 159
Rusch, V. W., Klimstra, D. S., Linkov, I., & Dmitrovsky, E. (1995) · PubMed · Cited by 150
Survival following resection for second and third primary lung cancers
Mathisen, D. J., Jensik, R. J., Faber, L. P., & Kittle, C. F. (1984) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)38284-4 · Cited by 145
Hung, J. (1995) · JAMA · doi:10.1001/jama.273.7.558 · Cited by 101
Sequential molecular genetic changes in lung cancer development
Chung, G. T. Y. (1996) · Lung Cancer · doi:10.1016/0169-5002(96)84183-3 · Cited by 94
Pathways of Chromosome Alteration in Human Epithelial Cancers
Dutrillaux, B. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60710-1 · Cited by 88
Antioncogenes and Human Cancer
Carbone, D. P., & Minna, J. D. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.002315 · Cited by 77
Wu, S.-C., Lin, Z.-Q., Xu, C.-W., Koo, K., Huang, O.-L., & Xie, D.-Q. (1987) · CHEST Journal · doi:10.1378/chest.92.5.892 · Cited by 76
Synchronous Primary Lung Cancers
Ferguson, M. K. (1993) · CHEST Journal · doi:10.1378/chest.103.4_supplement.398s · Cited by 56
Sakamoto, H., Lewis, M. S., Kodama, H., Appella, E., & Sakaguchi, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8974 · Cited by 53
Fontanini, G., Vignati, S., Bigini, D., Basolo, F., Pingitore, R., Bevilacqua, G., Merlo, G. R., Ribechini, A., & Angeletti, C. A. (1994) · The Journal of Pathology · doi:10.1002/path.1711740105 · Cited by 53
(1992) · PubMed
Cited by
Herbst, R. S., Heymach, J. V., & Lippman, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802714 · Cited by 2,389
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
Cancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Chung, K. F., & Adcock, I. M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00018908 · Cited by 599
Metadata
- Authors
- Franklin, W. A., Gazdar, A. F., Haney, J., Wistuba, I. I., La Rosa, F. G., Kennedy, T., Ritchey, D. M., & Miller, Y. E.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-10-15
- Volume
- 100
- Issue
- 8
- Pages
- 2133-2137
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1978499139
- Cited by
- 330
- References
- 38
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.